logo
logo

Dalrada Corporation Enters Into A $3Mm Convertible Debt Funding

Dalrada Corporation Enters Into A $3Mm Convertible Debt Funding

02/09/22, 1:00 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan diego
Dalrada Corporation (OTCQB: DFCO, "Dalrada") (“Company”) announces that as of February 4, 2022, Dalrada Financial Corporation (the “Company”) entered into a securities purchase agreement ("SPA") for issuance and sale of convertible debentures (the “Debentures”) in the aggregate principal amount of $3,000,000. The first Debenture in a principal amount of $2,000,000 was purchased upon the signing of the SPA on February 7, 2022 (the “First Closing”), and the second Debenture in the principal amount of $1,000,000 shall be purchased upon the filing of a registration statement with the U.S. Securities and Exchange Commission registering the resale of the shares of Common Stock underlying the Debenture by the Buyer (the “Second Closing”).

Company Info

Company
Dalrada (Dfco)
Location
san diego, california, united states
Additional Info
With perseverance, valor, dedication, and vision, Dalrada Corporation is dedicated to tackling the worldwide challenges of today and tomorrow. Dalrada is a global company that operates under the tenet of creating impactful innovations that matter for the world. The Company works continually to produce disruptive solutions that bridge the gap of accessibility and accelerate positive change for current and future generations. Established in 1982, the Company has since grown its footprint to include the business divisions: Dalrada Health, Dalrada Precision, and Dalrada Technologies. Dalrada's subsidiaries actively produce affordable and accessible world-class solutions to global problems. For more information, please visit www.dalrada.com.